For example, the resistance of gastric cancer cells to anti-tumor drugs (DDP, 5-FU) was increased significantly after P53 gene mutation (Menon & Povirk, 2014; Matsuhashi et al., 2005; Cascinu et al., 1998). This evidence concerns the gene TP53 and gastric cancer.